What's new

Human medicines European public assessment report (EPAR): Zefylti, filgrastim, Date of authorisation: 12/02/2025, Status: Authorised

Human medicines European public assessment report (EPAR): Zefylti, filgrastim, Date of authorisation: 12/02/2025, Status: Authorised

Mar 10, 2025 - 17:35
 0
Human medicines European public assessment report (EPAR): Zefylti, filgrastim, Date of authorisation: 12/02/2025, Status: Authorised
Human medicines European public assessment report (EPAR): Zefylti, filgrastim, Date of authorisation: 12/02/2025, Status: Authorised
Read More

Tags:

Previous Article

Digital sales transform the global beauty landscape, finds NIQ

Next Article

Inspira's $240M plan to enhance capacity, efficiency

Related Posts

Human medicines European public assessment report (EPAR): Docetaxel Accord, docetaxel, Date of authorisation: 22/05/2012, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 13, 2025  0

Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation: 15/09/2022, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0

EMEA-002904-PIP01-20-M01

EMEA-002904-PIP01-20-M01

Feb 19, 2025  0